Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
12/2009
12/16/2009CN101601765A Anal-intestinal health lotion and preparation method thereof
12/16/2009CN101601763A Traditional Chinese medicine formula for treating primary high blood pressure and preparation method thereof
12/16/2009CN101601754A Method for preparing Qingkailing capsules
12/16/2009CN101601752A Manufacturing method of rapid antihypertensive medicinal granules
12/16/2009CN101601735A Patch for treating hypertension and manufacturing method thereof
12/16/2009CN101601727A Thrombus-dredging wine drug
12/16/2009CN101601718A Manufacturing method of medicine for rapidly curing new and old haemorrhoids
12/16/2009CN101601715A Traditional Chinese medicinal granule for curing hemorrhoids and preparation method thereof
12/16/2009CN101601710A Application of traditional Chinese medicine composition in preparation of medicament for preventing and treating cerebral ischemia
12/16/2009CN101601686A Chinese medicinal preparation for treating hemorrhoids and preparation method thereof
12/16/2009CN101601679A Application of nicotinamide mononucleotide
12/16/2009CN101601678A Application of icariine for preparing vascular dilation drug
12/16/2009CN101601665A Use of 1r, 2s-methoxamine in preparing medicament for treating faecal incontinence and other conditions
12/16/2009CN101601660A Soluble tablet containing clopidogrel
12/16/2009CN101601656A Edaravone liposome injection and new application thereof
12/16/2009CN101601654A Hydrochloric acid Fasudil liposome injection and new application thereof
12/16/2009CN101601647A Riboflavine sodium phosphate composition injection and preparation method thereof
12/16/2009CN101601644A Icariine injection and preparation method and application thereof
12/16/2009CN101601470A Lucid ganoderma grain vinegar
12/16/2009CN101601469A Health care medicinal liquor and preparation method thereof
12/16/2009CN100570357C Detection method of 'Sheng Mai' particle
12/16/2009CN100569936C Acanthopanax-root wine and its production method
12/16/2009CN100569796C Immune modulating peptide
12/16/2009CN100569753C A crystalline of 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide methanesulfonate a process for preparing the same
12/16/2009CN100569297C Gene transfer-mediated angiogenesis therapy
12/16/2009CN100569281C Preparation and use of compositions for treating and preventing necrosis
12/16/2009CN100569275C Oil-solvent extraction of ginger extract
12/16/2009CN100569261C Chinese medicine dispersion tablet for treating coronary heart disease and angina pectoris and preparing process thereof
12/16/2009CN100569252C Medicne for treating primary hypertension and its preparation method
12/16/2009CN100569250C Medicine composition for preventing and treating myocardial ischemia disease
12/16/2009CN100569246C Composition containing butylbenzene peptide
12/16/2009CN100569244C Self emulsified soft capsule of ginkgo leaf extract and its preparing method
12/16/2009CN100569231C Red sage root salvianolic acid A tablet for treating cardiovascular disease and preparation process thereof
12/16/2009CN100569219C Composition of oral medicine preparation and its preparing method
12/15/2009US7632951 Inhibitors of integrin ανβ6
12/15/2009US7632870 Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives, preparation and uses thereof
12/15/2009US7632858 For example, 1-(4-Cyano-2-ethyl-3-(trifluoromethyl)phenyl-1-carbamoyl)-3-hydroxy-pyrrolidine-2-carboxylic acid methyl ester; may be used in treatment of diseases or disorders associated with androgen receptor activity, such as maintenance of muscle strength and function in the elderly
12/15/2009US7632850 2-amino-2-oxoethyl 1-(4'-fluoro-1,1'-biphenyl-4-yl)cyclopropylmethylcarbamate and 2-(methylamino)-2-oxoethyl 1-(4'-fluoro-1,1'-biphenyl-4-yl)cyclopropylmethylcarbamate; fatty acid amide (FAAH) hyrdrolase inhibitors; analgesics; neuropathic pain;psychological disorders; anticarcinogenic agents; AIDS
12/15/2009US7632815 Treating or preventing myocardial contractile dysfunction that occurs after a myocardial infarction or other structural heart disease (e.g., end-stage valve disease) by by administering CaMK11 inhibitor, a peptide having a specific sequence of amino acids; dilated cardiomyopathy; transgenic animals
12/15/2009US7632808 Use of MP52 or MP121 for the treatment and prevention of diseases of the nervous system
12/15/2009CA2537400C .gamma. crystalline form of ivabradine chlorhydrate, process for the preparation thereof and pharmaceutical compounds containing it
12/15/2009CA2501820C Chitosan-containing polysaccharide, method for preparing the same and use thereof
12/15/2009CA2424884C Substituted (e)-styryl benzylsulfones for treating proliferative disorders
12/15/2009CA2422698C Indoline derivatives and their use as 5-ht2 receptor ligands
12/15/2009CA2419302C Use of 2-iminobiotin for the prevention or treatment of perinatal asphyxia in neonates
12/15/2009CA2393437C Exo-s-mecamylamine formulation and use in treatment
12/15/2009CA2388915C Process for the preparation of n-(4,5-bismethanesulfonyl-2-methyl-benzoyl)guanidine, hydrochloride
12/15/2009CA2373180C Propanoic acid derivatives that inhibit the binding of integrins to their receptors
12/15/2009CA2348445C Compositions for the treatment and prevention of cardiovascular diseases
12/15/2009CA2347905C P53 antisense agent and method
12/15/2009CA2345138C Polymer conjugates of interferon beta-1a and their uses
12/15/2009CA2339008C Methods for increasing cytidine levels in vivo and treating cytidine-dependent human diseases
12/15/2009CA2338000C Water-soluble 4-thio-maleimido derivatives and methods for their production
12/15/2009CA2334189C Bridged indenopyrrolocarbazoles
12/15/2009CA2333125C Alpha emitting constructs and uses thereof
12/15/2009CA2308604C Antibodies against phosphorylated vasp (vasodilator-stimulated phosphoprotein), hybridoma cells for their preparation, and their use
12/15/2009CA2295195C Compositions and methods for preventing restenosis following revascularization procedures
12/15/2009CA2294996C Angiotensin derivatives
12/15/2009CA2267175C Alpha-9 integrin antagonists and anti-inflammatory compositions thereof
12/10/2009WO2009149344A2 Solid states of aliskiren free base
12/10/2009WO2009149161A2 Chimeric natriuretic polypeptides and methods for inhibiting cardiac remodeling
12/10/2009WO2009149148A2 Long-acting glp-1 derivatives, and methods of treating cardiac dysfunction
12/10/2009WO2009148990A1 Pulsatile release of valsartan
12/10/2009WO2009148684A1 Botanical composition and its uses
12/10/2009WO2009148620A2 Anthraquinones and analogs from rhuem palmatum for treatment of estrogen receptor beta-mediated conditions
12/10/2009WO2009147742A1 Sirna of human osteopontin
12/10/2009WO2009147702A1 Cerebroprotective agent
12/10/2009WO2009147679A1 Use of fts for the treatment of myocardial ischemia/reperfusion injury
12/10/2009WO2009147637A1 Compositions comprising amino acids, with pro-angiogenic activity
12/10/2009WO2009147441A2 Novel treatments
12/10/2009WO2009147218A1 Pharmaceutical combination
12/10/2009WO2009147187A1 4-carboxamide indazole derivatives useful as inhibitors of p13-kinases
12/10/2009WO2009146608A1 Pharmaceutical compositions containing imidazole-5-carboxylic acid derivatives and preparation method and use thereof
12/10/2009WO2009127922A3 Pharmaceutical formulation for treating cardiovascular disease
12/10/2009WO2009125981A3 Pharmaceutical formulation
12/10/2009WO2009118759A3 Heterocyclic compounds as adenosine receptor antagonist
12/10/2009WO2009109616A3 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cxrl and p40
12/10/2009WO2009104184A3 Extracts of sclerocarya birrea
12/10/2009WO2009095163A3 Cyclic indole-3-carboxamides, their preparation and their use as pharmaceuticals
12/10/2009WO2009054994A3 Use of compounds activating sirt-3 for mimicking exercise
12/10/2009US20090306408 2-Amino-Bicyclo (3.1.0) Hexane-2,6-Dicarboxylic Ester Derivative
12/10/2009US20090306197 Substituted Chromanol Derivatives and Their Use
12/10/2009US20090306190 Neuroprotectants
12/10/2009US20090306181 Compositions and methods for evaluating and treating heart failure
12/10/2009US20090306180 Compounds and methods for modulating expression apob
12/10/2009US20090306173 Crystalline forms of atorvastatin magnesium
12/10/2009US20090306161 Methods of treating alpha adrenergic mediated conditions
12/10/2009US20090306159 Inhibition of Intermediate-Conductance Calcium Activated Potassium Channels in the Treatment and/or Prevention of Atherosclerosis
12/10/2009US20090306151 Pharmaceutical preparation containing an angiotensin II receptor antagonist and a calcium channel blocker
12/10/2009US20090306133 New Acetyl Coenzyme A Carboxylase (ACC) Inhibitors And Uses In Treatments Of Obesity And Diabetes Mellitus - 087
12/10/2009US20090306120 Terpolymers containing lactide and glycolide
12/10/2009US20090306117 Rosuvastatin zinc salt
12/10/2009US20090306113 Pharmaceutical formulation
12/10/2009US20090306081 Solid Dosage Formulations of Hydralazine Compounds and Nitric Oxide Donor Compounds
12/10/2009US20090306079 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands
12/10/2009US20090306074 Thiazolidinedione derivatives as p13 kinase inhibitors
12/10/2009US20090306069 Azolidinone-vinyl fused-benzene derivatives
12/10/2009US20090306064 5-[4-(3-Methoxypropyl)3.4-dihydro-2H-benzo[1,4]oxazin-6-ylmethoxy]-4 -(4-phenoxyphenyl)-piperidin-3-ol, used for treating high blood pressure, glaucoma, myocardial infarction, restenoses or stroke
12/10/2009US20090306055 Phenylazole compounds, production process and antioxidants
12/10/2009US20090306053 Highly selective rho-kinase inhibitor
1 ... 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 ... 1595